Development of real-time RT-PCR assays for detection of three classes of HHV-6A gene transcripts
Development of real-time RT-PCR assays for detection of three classes of HHV-6A gene transcripts
复制标题
开发用于检测三类 HHV-6A 基因转录本的实时 RT-PCR 检测方法
DOI:
10.1002/jmv.24862
复制
发表时间:
2017
影响因子:
12.7
通讯作者:
Yoshikawa T
中科院分区:
文献类型:
--
作者:
Ihira M;Urashima A;Miura H;Hattori F;Kawamura Y;Sugata K;Yoshikawa T
Human herpesvirus 6 (HHV‐6), a member of the betaherpesvirus family, has two distinct species: HHV‐6A and HHV‐6B. HHV‐6B real‐time reverse transcription polymerase chain reaction (RT‐PCR) has been used to distinguish between active and latent viral infection. In this study, we developed a real‐time RT‐PCR assay to detect HHV‐6A‐specific transcripts and evaluated its reliability for analysis of clinical samples. To develop HHV‐6A‐specific real‐time RT‐PCR assays, three different classes of gene transcripts (immediate early: U90; early: U12; and late: U100) were selected as targets. Serial d ilutions of plasmid DNAs containing target sequences and RNAs extracted from HHV‐6A‐infected cells were used to determine assay specificity and sensitivity. Peripheral blood mononuclear cells (PBMCs) collected from patients with either primary or reactivated HHV‐6B infection, and one patient with X‐linked severe combined immunodeficiency (X‐SCID) with HHV‐6A reactivation, were used to evaluate assay reliability. The HHV‐6A‐specific real‐time RT‐PCR assays amplified plasmids containing the target sequences at concentrations between 10 and 1 × 106copies per reaction. The intra‐assay coefficients of variation were less than 5%. The three classes of HHV‐6A gene transcripts were not detected in any HHV‐6B sample isolated from the patients. In the X‐SCID patient, high copy numbers of HHV‐6A U12 and U100 transcripts were detected in PBMC samples during viremia. Thus, we successfully established highly sensitive and reproducible real‐time RT‐PCR methods targeting three classes of HHV‐6A gene transcripts. This method should be useful for discriminating active HHV‐6A infection from either latent infection or chromosomally integrated HHV‐6A (ciHHV‐6A).